Skip to player
Skip to main content
Skip to footer
Search
Connect
Watch fullscreen
Like
Comments
Bookmark
Share
Add to Playlist
Report
Disaster Stock Of The Day: Humana Faces Sharp Decline In Medicare Star Ratings For 2025, Braces For 2026 Revenue Hit
Benzinga
Follow
10/2/2024
According to preliminary data from the Centers for Medicare and Medicaid Services (CMS), Humana Inc. (NYSE:HUM) faces a substantial drop in its Medicare Advantage (MA) Star Ratings for 2025.
Category
🗞
News
Transcript
Display full video transcript
00:00
Wow, I don't even know what to say here.
00:03
I kind of want to start with Humana,
00:04
even though we have so many other stories.
00:06
We have war, China, so many things to talk about,
00:10
but this Humana just jumps out
00:12
like a sore thumb on my screen here today.
00:15
It gets rocked for like 30 bucks yesterday
00:19
and people coming and buying the dips.
00:21
I saw them saying, yep, buy the dip.
00:23
This goes to show, don't buy the dip on day one.
00:27
You usually don't want to buy the dip on day one
00:29
when it's a bad headline.
00:31
And we get the bad headline.
00:33
Now you get multiple analysts commentary here
00:35
talking about their earnings getting whacked.
00:38
A, B, give us these details here on Humana
00:40
because this stock is your disaster stock of the day.
00:44
Yeah, and the title of the show,
00:46
an unhealthy market because you know, of course,
00:49
Humana, the healthcare insurance company.
00:52
So basically they're these Medicare Advantage star ratings.
00:58
Last year, 94% of Humana's members
01:03
had four stars or higher.
01:05
So either four stars, four and a half stars
01:07
or five stars on this plan.
01:09
This year, a change in some sort of contract
01:14
is now leaving Humana with only 25% of its members
01:18
in plans rated four stars or higher.
01:21
So last year they had 94% of their members
01:23
in four star or higher plans.
01:25
This year, it's only set to be 25%,
01:29
which then limits the amount of money
01:32
that Humana gets for different things
01:36
from like the government and stuff.
01:38
So either way, the plans here,
01:42
the Medicare Advantage star ratings here
01:45
is bad news for Humana.
01:47
They're saying, the article that I read this morning
01:49
is saying that there could be some,
01:51
despite appealing potential errors
01:54
in the rating calculations
01:55
and actively working on improvement strategies
01:58
to boost future performance and quality payouts,
02:00
Humana acknowledges increased risk
02:03
in meeting its financial targets
02:04
while remaining committed to enhancing value
02:06
for customers and shareholders.
02:08
So either way, it sounds like Humana came out
02:10
and said like, yeah, this isn't good
02:11
for our financial targets,
02:12
but they're trying to work on it.
02:15
That's basically the headline.
02:16
What's hammering Humana, not just this morning,
02:18
but hit yesterday as well.
02:21
And it appears what Humana's loss is,
02:25
seems to be UNH and the other healthcare providers
02:28
gain here, because UNH is ripping this morning.
02:31
It's up 15 points.
02:32
CVS is trading up another 4% here.
02:35
We know they got the Aetna back on them.
02:39
This is a hard one to figure out,
02:40
the Love Triangle and obviously there's others,
02:43
there's CI, WellPoint or whatever it is, WellCare.
02:48
There's just a pile of these things
02:51
that are going to trade.
02:52
It's a tough one to figure out,
02:54
because naturally thinking, you'd think like,
02:56
well, Humana getting whacked,
02:58
they're going to whack UNH too,
03:00
but that is not happening.
03:02
That is not happening at all.
03:03
The opposite is occurring,
03:04
where UNH is actually rallying on this.
03:06
So this is very interesting.
Recommended
1:00
|
Up next
UnitedHealth Names New CEO, Suspends 2025 Guidance, Stock Plunges
Benzinga
5/13/2025
1:06
United Health Stock Is Sliding Today- What's Going On?
Benzinga
7/2/2025
3:56
AI And Genomics News From The J.P. Morgan Health Conference 2024 - Lis Agosto, Healthcare Analyst At GlobalX ETFs
Benzinga
1/10/2024
0:49
Newsmax And The Curious Case of MAGA Media: Is The 2200% Rally In 2 Days An Anomaly Or A Trend?
Benzinga
4/2/2025
13:34
"The Second Half Of September Is When The Trouble Tends To Come" - Ryan Detrick, CMT, Carson Group
Benzinga
9/5/2024
6:02
Deadly E. Coli Outbreak Linked To McDonald's Quarter Pounders Sends Stock Tumbling: What Investors Need To Know
Benzinga
10/23/2024
3:05
Crowded Trades & Valuations: Good Companies, Bad Stocks
Benzinga
9/9/2024
4:16
Piper's Sandler's Craig Johnson Puts $6,600 Target On $SPX For 2025
Benzinga
10/24/2024
1:12
Robinhood Markets (HOOD) Stock Hits A New All-Time High- What's Going On?
Benzinga
6/25/2025
1:16
US Economy Adds 818,000 Fewer Jobs Than Initially Reported: Urgency For Interest Rate Cuts Grows Further
Benzinga
8/21/2024
4:12
No Bid For Defensives and What Are The Bond Markets Telling Us? - Cameron Dawson, CFA, Chief Investment Officer, NewEdge Wealth
Benzinga
8/15/2023
3:44
Shares Of Insurance Companies Are Trading Lower While Floridians Experience Evacuation Orders As Cat 5 Hurricane Milton Approaches
Benzinga
10/8/2024
7:29
RTX Earnings And How Does The Media Figure Out What's Happening With A Volatile Stock When There's No Obvious News?
Benzinga
7/25/2023
5:13
Is This A Buy The Dip Opportunity In The Stock Market?
Benzinga
6/26/2023
3:04
How End Of Month Buy And Sell Imbalances Effected Stock Movements
Benzinga
6/1/2023
14:28
Managing Your Wealth (and sanity) In An Election Year - Ryan Detrick, Carson Group
Benzinga
10/25/2024
1:45
Are Housing Stocks Pointing Towards A Recession? - $TOL
Benzinga
5/4/2023
10:40
Are Interest Rates Going To Stay Higher For Longer Based On The CPI Data Released On Tuesday?
Benzinga
2/14/2024
7:24
Citius Pharmaceuticals (NASDAQ: $CTXR): Late-Stage Assets, Strategic Mergers & Upcoming Catalysts
Benzinga
7/30/2024
7:13
From Meme to Market: Apu Apustaja's Journey to a $380M Market Cap
Benzinga
7/22/2024
5:41
Earnings Highlights & A Huge Upcoming Catalyst For Viking Therapeutics, Mark This Date
Benzinga
10/24/2024
0:56
Nuclear Stock Oklo Continues To Climb: What's Going On?
Benzinga
10/22/2024
0:38
Trump Media & Technology Stock Falls Over 5% Premarket Ahead Of First Session Post-Inauguration
Benzinga
1/21/2025
1:31
Why Is The Fed Still So Aggressive? - Jeremy Schwartz, Chief Investment Officer at WisdomTree
Benzinga
7/12/2023
0:39
Asana Announces $150 Million Stock Buyback: What To Know
Benzinga
6/21/2024